Skip to main content
Scienture Holdings, Inc. logo

Scienture Holdings, Inc. — Investor Relations & Filings

Ticker · SCNX ISIN · US89846A2078 US Manufacturing
Open in API
Filings indexed 495 across all filing types
Latest filing 2026-05-29 Board/Management Inform…
Country US United States of America
Listing US SCNX

About Scienture Holdings, Inc.

https://www.trxadehealth.com/

Scienture Holdings, Inc. is a holding company that operates through its subsidiaries, including Scienture, LLC and Integra Pharma Solutions, LLC. The company functions as an integrated pharmaceutical and health services provider focused on the development, commercialization, and distribution of novel specialty products. A key therapeutic area includes treatments for central nervous system disorders. Scienture Holdings aims to enhance value for patients and physicians by addressing the needs of underserved populations and bridging gaps in treatment delivery systems to improve healthcare outcomes. The company also provides a web-based purchasing platform for transactions.

Recent filings

Filing Released Lang Actions
8-K
Board/Management Information Classification · 90% confidence The document is a Form 8-K current report filed under Item 5.02, which details the resignation of the CFO and appointment of an interim CFO. This is a clear announcement of changes in senior management, fitting the Board/Management Information category.
2026-05-29 English
8-K
Earnings Release Classification · 84% confidence The document is a Form 8-K current report under Item 2.02 “Results of Operations and Financial Condition,” furnishing a press release announcing quarterly financial results for the period ended March 31, 2026. This aligns with the definition of an Earnings Release (ER): an initial announcement of periodical financial results (key highlights only). Q1 2026
2026-05-22 English
10-Q
Interim / Quarterly Report Q1 2026
2026-05-15 English
8-K - Scienture Holdings, Inc. (0001382574) (Filer)
Investor Presentation Classification · 89% confidence The document is a Form 8-K Current Report under Item 7.01 disclosing that the company posted and furnished a revised investor presentation as Exhibit 99.1. This is a clear example of an investor presentation being attached and presented to investors. Thus, it falls under the “Investor Presentation” category (Code: IP).
2026-05-05 English
8-K - Scienture Holdings, Inc. (0001382574) (Filer)
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report pursuant to the Securities Exchange Act of 1934. It details the entry into a material definitive agreement involving secured promissory notes and financing arrangements. The content focuses on a financing transaction, including terms of notes, interest rates, covenants, and security interests. There is no indication that this is a full annual or quarterly report, audit report, earnings release, or other types of filings. The document is not a brief announcement but a detailed disclosure of a capital raising event. Therefore, it fits the category of Capital/Financing Update (CAP). The document length (15,000 characters) supports that it is a substantive filing rather than a brief announcement or certification. Confidence is high given the clear description of financing terms and the nature of the Form 8-K item reported (Item 1.01 and 2.03 related to material definitive agreements and financial obligations).
2026-05-01 English
10-K/A - Scienture Holdings, Inc. (0001382574) (Filer)
Annual Report FY 2025
2026-04-30 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.